Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Veterinary Pain Management Market Report by Product, Animal Type, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The global veterinary pain management market size reached US$ 1.5 Billion in 2023 and is projected to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.84% during 2023-2032.
The increasing domestication of animals, along with the rising awareness regarding pet health among the masses, is one of the key factors driving the growth of the market.
Moreover, the convenient availability of pain management products and devices, including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), laser devices and local anesthetics, is providing a thrust to the market growth. These solutions provide relief from the pain caused by musculoskeletal disorders, radiotherapy-induced pain, chemotherapy, osteoarthritis and mastitis. In line with this, the widespread adoption of laser therapy as an effective solution for pain management is also contributing to the market growth. Laser therapy provides significant pain-relief and also aids in regenerating nerve tissue post-surgery.
Additionally, a significant increase in the livestock population suffering from cancer, abdominal and neuropathic pain is also creating a positive outlook for the market. Other factors, including the rising prevalence of inflammation and pain-causing diseases in domesticated animals, along with the widespread adoption of pet insurance services, are anticipated to drive the market toward growth.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global veterinary pain management market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on product, animal type, application and end user.
Breakup by Product:
- Drugs
- NSAIDs
- Anesthetics
- Opioids
- Other Drugs
- Devices
- Laser Therapy
- Electromagnetic Therapy
Breakup by Animal Type:
- Companion
- Livestock
Breakup by Application:
- Osteoarthritis and Joint Pain
- Postoperative Pain
- Cancer
- Others
Breakup by End User:
- Hospitals and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Assisi Animal Health, Bayer AG, Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG), Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eli Lilly and Company, Idexx Laboratories Inc., Merck & Co. Inc., Norbrook, Vetoquinol S.A. and Zoetis Inc.
Key Questions Answered in This Report
- How big is the global veterinary pain management market?
- What is the expected growth rate of the global veterinary pain management market during 2024-2032?
- What are the key factors driving the global veterinary pain management market?
- What has been the impact of COVID-19 on the global veterinary pain management market?
- What is the breakup of the global veterinary pain management market based on the product?
- What is the breakup of the global veterinary pain management market based on the application?
- What is the breakup of the global veterinary pain management market based on the end user?
- What are the key regions in the global veterinary pain management market?
- Who are the key players/companies in the global veterinary pain management market?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 138 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $1.5 Billion |
| Forecasted Market Value (USD) by 2032 | $2.5 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
Companies Featured
- Assisi Animal Health
- Bayer AG
- Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
- Ceva Sante Animale
- Chanelle Pharma
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Idexx Laboratories Inc.
- Merck & Co. Inc.
- Norbrook
- Vetoquinol S.A.
- Zoetis Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ruo5zk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
